What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism

BACKGROUND: The private sector supplies anti-malarial treatment for large proportions of patients in sub-Saharan Africa. Following the large-scale piloting of the Affordable Medicines Facility-malaria (AMFm) from 2010 to 2011, a private sector co-payment mechanism (CPM) provided continuation of priv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tougher, Sarah, Hanson, Kara, Goodman, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405529/
https://www.ncbi.nlm.nih.gov/pubmed/28441956
http://dx.doi.org/10.1186/s12936-017-1814-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405529/
https://www.ncbi.nlm.nih.gov/pubmed/28441956
http://dx.doi.org/10.1186/s12936-017-1814-z

Ejemplares similares